Published in Cancer on November 15, 2006
Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther (2011) 1.08
Clinical exercise interventions in prostate cancer patients--a systematic review of randomized controlled trials. Support Care Cancer (2011) 0.99
Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma. Oncol Nurs Forum (2008) 0.95
UW WELL-FIT: the impact of supervised exercise programs on physical capacity and quality of life in individuals receiving treatment for cancer. Support Care Cancer (2011) 0.93
Effects of a supervised exercise intervention on recovery from treatment regimens in breast cancer survivors. Oncol Nurs Forum (2008) 0.89
Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails. Onco Targets Ther (2016) 0.84
Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors. Support Care Cancer (2012) 0.82
Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors. J Oncol (2015) 0.78
Exercise tolerance in breast cancer patients during radiotherapy after aerobic training. Contemp Oncol (Pozn) (2013) 0.77
Effect of an exercise training intervention with resistance bands on blood cell counts during chemotherapy for lung cancer: a pilot randomized controlled trial. Springerplus (2014) 0.76
Impact of moderate intensity aerobic exercise on chemotherapy-induced anemia in elderly women with breast cancer: A randomized controlled clinical trial. J Adv Res (2016) 0.75
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2012) 4.42
Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. Mol Pain (2008) 1.33
Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res (2002) 1.29
A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur J Pharm Biopharm (2002) 1.12
Injection drug use: an understudied cause of venous disease. Arch Dermatol (2007) 1.09
Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int J Pharm (2002) 1.01
Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens. Obes Res (2004) 0.94
Discovery of okilactomycin and congeners from Streptomyces scabrisporus by antisense differential sensitivity assay targeting ribosomal protein S4. J Antibiot (Tokyo) (2009) 0.87
Double-blinded, placebo-controlled trial of midodrine for exercise performance enhancement in tetraplegia: a pilot study. J Spinal Cord Med (2004) 0.86
Quality of life as a predictor of weight loss in obese, early-stage breast cancer survivors. Oncol Nurs Forum (2007) 0.86
Discovery and antibacterial activity of glabramycin A-C from Neosartorya glabra by an antisense strategy. J Antibiot (Tokyo) (2009) 0.85
Effects of injection--drug injury on ankle mobility and chronic venous disorders. J Nurs Scholarsh (2007) 0.85
Reliability and clinical validity of a technique to assess lifetime illicit injection drug use. Ostomy Wound Manage (2008) 0.82
Venous ulcers: A reappraisal analyzing the effects of neuropathy, muscle involvement, and range of motion upon gait and calf muscle function. Wound Repair Regen (2009) 0.81
The standing heel-rise test: relation to chronic venous disorders and balance, gait, and walk time in injection drug users. Ostomy Wound Manage (2008) 0.80
ACOEM practice guidelines: elbow disorders. J Occup Environ Med (2013) 0.80
Coniothyrione, a chlorocyclopentandienylbenzopyrone as a bacterial protein synthesis inhibitor discovered by antisense technology. J Nat Prod (2007) 0.80
Impact of injection drug use on distribution and severity of chronic venous disorders. Wound Repair Regen (2009) 0.80
Nodulisporic acids C, C1, and C2: a series of D-ring-opened nodulisporic acids from the fungus Nodulisporium sp. J Nat Prod (2003) 0.79
Isolation, structure, and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. discovered by antisense strategy. J Nat Prod (2008) 0.78
Isolation, structure and antibacterial activity of pleosporone from a pleosporalean ascomycete discovered by using antisense strategy. Bioorg Med Chem (2008) 0.78
Chronic venous disorders and injection drug use: impact on balance, gait, and walk speed. J Wound Ostomy Continence Nurs (2008) 0.77
Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying. Pharm Res (2003) 0.76
The impact of vascular leg disorders on physical activity in methadone-maintained adults. Res Nurs Health (2010) 0.76
Investigation of processing parameters of spray freezing into liquid to prepare polyethylene glycol polymeric particles for drug delivery. AAPS PharmSciTech (2003) 0.75
Chronic venous disease and injection drug use. Arch Intern Med (2007) 0.75
Injection-related venous disease and walking mobility. J Addict Dis (2010) 0.75
Substance abuse and chronic venous disorders. West J Nurs Res (2009) 0.75
Relationship of psychiatric diagnosis and weight loss maintenance in obese breast cancer survivors. Obes Res (2003) 0.75
Exercise and urologic cancers. Urol Oncol (2008) 0.75
Peripheral arterial disease among substance abusers in drug treatment. Adv Skin Wound Care (2009) 0.75
81-year-old woman with nausea, fatigue, and shortness of breath. Mayo Clin Proc (2004) 0.75